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Synthetic biology is principally concerned with the rational design and engineering of biolog-
ically based parts, devices, or systems. However, biological systems are generally complex
and unpredictable, and are therefore, intrinsically difficult to engineer. In order to address
these fundamental challenges, synthetic biology is aiming to unify a “body of knowledge”
from several foundational scientific fields, within the context of a set of engineering princi-
ples. This shift in perspective is enabling synthetic biologists to address complexity, such
that robust biological systems can be designed, assembled, and tested as part of a biolog-
ical design cycle. The design cycle takes a forward-design approach in which a biological
system is specified, modeled, analyzed, assembled, and its functionality tested. At each
stage of the design cycle, an expanding repertoire of tools is being developed. In this
review, we highlight several of these tools in terms of their applications and benefits to
the synthetic biology community.
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INTRODUCTION
The synthetic biology toolkit has expanded greatly in recent years,
which can be attributed to the efforts of a highly dynamic commu-
nity of researchers, ambitious undergraduate students in the Inter-
national Genetically Engineered Machine competition (iGEM),
and the growing number of amateur scientists from the DIY
BIO movement. Each of these groups has bold ambitions for the
rapidly growing field of synthetic biology, which aims to ratio-
nally engineer biological systems for useful purposes (Purnick and
Weiss, 2009; Anderson et al., 2012; Landrain et al., 2013; Jeffer-
son et al., 2014). The merging of several foundational sciences,
including molecular, cellular, and microbiology with a set of engi-
neering principles, is a profound shift and is the key distinction
between synthetic biology and genetic engineering (Andrianan-
toandro et al., 2006; Heinemann and Panke, 2006; Khalil and
Collins, 2010; Kitney and Freemont, 2012). Indeed, many social
scientists, who are themselves a part of the synthetic biology
community, have extensively explored the ontological implica-
tions of this perspective (Schark, 2012; Preston, 2013). Although
many of the social aspects of synthetic biology are beyond the
scope of this review, they will continue to shape the synthetic
biology toolkit. In particular, society is an important stakeholder
that has some influence over chassis (host cell) choice, the design
of biosafety measures, biosecurity considerations, and long-term
research applications (Marris and Rose, 2010; Anderson et al.,
2012; Agapakis, 2013; Moe-Behrens et al., 2013; Wright et al., 2013;
Douglas and Stemerding, 2014).
From a biological perspective, there have been important devel-
opments in the field across several areas, some of which have been
reviewed elsewhere (Arpino et al., 2013; Lienert et al., 2014; Way
et al., 2014). For instance, the number, quality, and availability
of biological parts (bioparts, e.g., promoters and ribosomal bind-
ing sites) have continued to increase. This is exemplified by the
iGEM student registry of standard biological parts, which has
increased its biopart collection to include over 12,000 parts, across
20 different categories (partsregistry.org). However, due to its open
nature, the iGEM registry contains parts of variable quality that
are mostly uncharacterized. There are also professional parts reg-
istries, such as those at BIOFAB, which include expansive libraries
of characterized DNA-based regulatory elements (Mutalik et al.,
2013a,b). Although libraries of bioparts are indeed useful, putting
them together into predictable devices, pathways and systems are
incredibly challenging as many biological design rules are not
yet fully understood (Endy, 2005; Kitney and Freemont, 2012).
Developing synthetic passive and active insulator sequences may
help increase predictability and thus reduce context dependency
(Davis et al., 2011; Lou et al., 2012; Qi et al., 2012; Mutalik et al.,
2013a). Notwithstanding these challenges, the field is progress-
ing across several areas. One such area is biopart characterization,
which is critical to the field, primarily because it is fundamen-
tally a realization of several of the core engineering principles
adopted in synthetic biology, namely standardization, modulariza-
tion, and abstraction. Discrete biological parts of known sequence
and behavior can be abstracted based upon a descriptive function
and thus, their true complexity can be masked behind a biological
concept. For example, discrete DNA sequences (bioparts) that fit
a standardized descriptive function, such as a promoter, can be
functionally characterized and as a consequence bioparts become
reusable (modularization) for use in other synthetic systems.
Additionally, methods that provide standardized ways of assem-
bling DNA parts such as the BioBrick standard can help estab-
lish platforms for the sharing and reuse of bioparts. At a higher
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level, abstraction and standardization are important because they
permit the separation of design from assembly (Endy, 2005).
A desirable consequence of this perspective is that these engi-
neering principles enable the separation of labor, expertise, and
complexity at each level of the design hierarchy (Endy, 2005). In
practical terms, this separation of biological design from DNA
assembly enables innovation within these hierarchies to occur at
different rates. For instance, it is generally true that with more
recent DNA assembly methods it is currently easier to assemble
multi-part genetic circuits consisting of several bioparts, or even
entire genomes, than it is to reliably predict how these bioparts
will interact in the final system (Purnick and Weiss, 2009; Ellis
et al., 2011; Arpino et al., 2013; Ellefson et al., 2014). How-
ever, it is envisioned that this will change, with the increasing
adoption of high-throughput characterization platforms that can
test entire biopart libraries in parallel. These platforms typically
use automated liquid-handling robots, coupled with plate readers
although microfluidics approaches are also gaining traction (Lin
and Levchenko, 2012; Boehm et al., 2013; Benedetto et al., 2014).
In either case, when coupled with automated data analysis, mod-
eling, and sophisticated forward-design strategies (Marchisio and
Stelling, 2009; Wang et al., 2009; Esvelt et al., 2011; Ellefson et al.,
2014; Marchisio, 2014; Stanton et al., 2014), these high-throughput
platforms provide the basis for the rapid prototyping workflows
required to realize a synthetic biology design cycle (Kitney and
Freemont, 2012).
In this review, we focus on several significant tools, both clas-
sical and emerging, that the field of synthetic biology employs as
part of a typical design cycle workflow. Building upon a design
cycle template, the review is organized to explore prominent
tools and research methodologies across three core areas: design-
ing predictable biology (design), assembling DNA into bioparts,
pathways, and genomes (build), and rapid prototyping (test)
(Figure 1). We first describe several of the core challenges that are
associated with designing predictable biology, including the com-
plexities associated with chassis selection, biopart design, engi-
neering, and characterization. In parallel, we highlight relevant
tools and methodologies that are particularly aligned with the
engineering principles of synthetic biology. We then discuss estab-
lished and newly developed DNA assembly methodologies, and
group them according to four broad assembly strategies: restric-
tion enzyme-based, overlap-directed, recombination-based, and
DNA synthesis. Finally, we highlight several emerging rapid pro-
totyping technologies that are set to significantly improve the
field’s capacity for testing synthetic parts, devices, and systems.
We conclude with a summary of several of the core challenges
that were described in each of the design, build, test sections of
the review and discuss whether the synthetic biology toolbox is
equipped to address them. In addition to this, we have also cre-
ated an online community, the Synthetic Biology Index of Tools
and Software (SynBITS) – synBITS.co.uk, which has also been
structured according to the design cycle (Figure 1).
DESIGNING PREDICTABLE BIOLOGY
From an engineering perspective, living systems can be perceived
as overly complex, inefficient, and unpredictable (Csete and Doyle,
2002). It is this perception that has driven the concept of the
FIGURE 1 | Synthetic Biology Index ofTools and Software (SynBITS). A
schematic summary of the synthetic biology design cycle tools as depicted
in SynBITS (www.synbits.co.uk), an online community-managed index of
synthetic biology tools and software.
biopart, in which a particular DNA sequence is defined by the
function that it encodes (Endy, 2005). Thus, complex biolog-
ical functions can be conceptually separated (abstracted) from
the complexities of the sequence context from which they orig-
inated (Endy, 2005). As a consequence of this approach, bio-
logical pathways and circuits can potentially be redesigned into
less complex and potentially more predictable designs. The defin-
ing examples of this perspective are the toggle switch (Gardner
et al., 2000), a genetic circuit defined by two repressible promoters
that were engineered to form a mutually inhibitory network, and
the repressilator (Elowitz and Leibler, 2000), a type of oscillator
(biological clock). What sets these examples apart from general
genetic engineering is that modeling was used to predict and opti-
mize the behavior of these genetic circuit designs prior to their
construction.
While these forward-design approaches were hugely successful,
the repressilator displayed noisy behavior as a result of stochas-
tic fluctuations in components of the genetic circuit (Elowitz and
Leibler, 2000). In other words, in silico modeling did not fully
capture the true in vivo complexity of the synthetic circuit. Like-
wise, the toggle switch experienced natural fluctuations in gene
expression that were sufficient to create variations in the level
of inducer needed to switch the cells from one state to another.
These variations were also not fully anticipated during in silico
modeling (Gardner et al., 2000). While these genetic circuits have
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been improved, with novel oscillator (Stricker et al., 2008; Olson
et al., 2014) and toggle switch designs, including those designed
for mammalian cells (Muller et al., 2014b) and plants (Muller
et al., 2014a), it is clear that the modeling of biological systems
still requires a concerted and long-term effort. Critical to this
effort is the availability of new synthetically designed bioparts and
experimental data that accurately captures the behavior of the
components or bioparts that constitute a synthetic system (Arkin,
2013) as well as the characteristics or influence that the chassis/host
cell enacts upon them.
CHASSIS SELECTION
As an engineering concept, the chassis refers to a physical inter-
nal framework or structure that supports the addition of other
components that combine to form a finalized engineered struc-
ture. From a synthetic biology perspective, the concept invokes
an understanding that a biological chassis is a tool to provide
the structures that accommodate (host) the execution of a syn-
thetic system, including the provision of a metabolic environment,
energy sources, transcription, and translation machinery, as well
as other minimal cellular functions (Acevedo-Rocha et al., 2013;
Danchin and Sekowska, 2014). Chassis selection is therefore a crit-
ical design decision that synthetic biologists are required to take,
particularly since the chassis will directly influence the behav-
ior and function of a synthetic system. Essentially, the chassis
determines which bioparts can be used since they must be com-
patible with the biological machinery that is present. This can
result in a difficult choice for the synthetic biologist: either to
use an established chassis and design the circuit to be orthogonal
with that host, or design a synthetic system that fits a requirement
and then choose a host chassis that is compatible with the resul-
tant bioparts or system. These constraints can to some degree be
designed around, either by engineering the chassis to knockout
genes that optimize its orthogonality and reduce burden, through
codon optimization (Chung and Lee, 2012) or through the use of
insulator sequences that negate context dependency effects (Guye
et al., 2013; Torella et al., 2014a). Ultimately, however, chassis selec-
tion will dictate the downstream design considerations for any
given synthetic system, and therefore, chassis selection must be
coordinated with biopart design efforts.
In order to rationalize which chassis selection strategy is most
appropriate for an intended application, it is important to consider
the consequences and advantages of each strategy. Where a chassis
is selected as a priority above that of the design considerations
of the synthetic system, it is important to consider whether the
chassis has been extensively characterized in the literature and/or
if the chassis has known intrinsic capabilities that complement
the intended application (Table 1). Additionally, access to detailed
biological knowledge of a chassis will aid modeling-guided design
efforts and the implementation of chassis optimization strategies
for dealing with burden or metabolic flux effects. Likewise, the
wealth of knowledge acquired about model organisms across sev-
eral biological disciplines may encourage synthetic biologists to
consider them as a potential chassis in preference to established
favorites (Table 1). Indeed, there are already several emerging
chassis that are gaining traction and are set to be utilized more
frequently in the field (Table 1).
Alternatively, a synthetic system could be specified and designed
as a priority above that of chassis selection. As a consequence, there
will be chassis, which are not compatible with the synthetic system
and others that may require extensive engineering to accommo-
date its design. However, this approach is complementary to those
chassis that are bespoke engineered. “Synthia,” the first organism
to feature a fully synthetically manufactured genome, is indicative
that the field of synthetic biology is shifting toward the devel-
opment of rationally engineered chassis (Gibson et al., 2010a).
Though it is important to recognize that the “Synthia” genome,
while synthetic in origin, was not designed to significantly alter
the characteristics of the chassis, and therefore, does not represent
the first truly bespoke-engineered chassis. Yet, its successors, the
synthetic yeast project (Annaluru et al., 2014), protocell develop-
ments (Xu et al., 2010),and even to some extent cell-free expression
systems (Shin and Noireaux, 2012; Sun et al., 2013a) may all usher
in an era in which the design of bespoke-engineered chassis is
routine. Wholly rationally engineered chassis could conceivably
be built around the specifications of a synthetic system, such that
the chassis is both compatible with the synthetic system and the
majority of its cellular resources are directed toward the execution
of the synthetic system. In this sense, the function of the synthetic
system would be free of chassis constraints; however, the full real-
ization of this approach is still several decades away. Until then,
chassis selection will remain a trade-off between which should be
prioritized for each application, the chassis or the synthetic system?
There are of course many other considerations to address, some
of which we cover in the biopart design section of this review
and others that have been previously discussed in the literature
(Heinemann and Panke, 2006; Arpino et al., 2013; Danchin and
Sekowska, 2014).
BIOPART DESIGN AND ENGINEERING
The field of synthetic biology continues to benefit from decades
of biological research that has built a knowledge base of biological
systems that can be deconstructed and re-engineered as bioparts
and synthetic systems. Here, we highlight prominent bioparts that
are particularly aligned with the engineering principles of syn-
thetic biology. In most cases, existing natural biological parts can
be reused in synthetic devices or systems. However, there are sit-
uations where new bioparts need to be designed and synthesized
by modifying existing bioparts or by creating entirely new parts de
novo. These novel parts could be enzymes that catalyze unnatural
reactions (Jiang et al., 2008; Rothlisberger et al., 2008), molecular
biosensors (Penchovsky and Breaker, 2005), protein scaffold (Koga
et al., 2012; Heider et al., 2014), DNA or RNA scaffolds (Rothe-
mund, 2006; Delebecque et al., 2011), ribosome-binding sites with
specifically designed transcription rates (Salis et al., 2009), pro-
moters with novel regulatory features and/or specific translation
rates (Marples et al., 2000; Kelly et al., 2009).
Transcriptional circuits use RNA polymerase operations
per second (PoPS) as the common signal carrier but, until recently
only a small set of DNA-binding proteins and associated opera-
tor sequences were used to regulate the flux of RNA polymerase
(RNAP) and construct synthetic circuits. The lack of a large set
of orthogonal regulatory proteins has limited the complexity of
synthetic systems (Purnick and Weiss, 2009), but a new wave of
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Table 1 | Synthetic biology chassis.
Chassis Advantages Disadvantages
ESTABLISHED CHASSIS
Bacillus subtilis Model Gram-positive organism. Generally regarded as safe (GRAS) organism.
Genetically tractable and genome sequences are available. Secretion of
proteins. Extensive range of molecular biology tools are available, e.g.,
plasmids (Harwood et al., 2013; Radeck et al., 2013). Rapid growth,
inexpensive to grow and maintain, can be induced to form heat and
desiccation resistant spores (Harwood et al., 2013). Spores can be transported
easily and cheaply. Suicide mechanisms are available (Wright et al., 2013).
Non-integrative plasmids are not always
stably maintained between cell generations.
Protease-deficient strains are required to
minimize proteolytic degradation of
expressed proteins.
Cell-free protein
synthesis
(CFPS)/transcription–
translation coupled
reactions (TX–TL)
Protein/metabolite production is decoupled from the need of the cell to
survive and reproduce – ideal if product is toxic or inhibitory to living chassis.
Amenable to high-throughput workflows (Sun et al., 2013a,b).
The biological system does not
self-reproduce
Reactions typically only last 4–6 h due to
depletion of the reaction energy mix and/or
the accumulation of inorganic phosphates.
Reaction components can also be expensive
Variability between cell extract batches
Escherichia coli Genetically tractable and genome sequences are available. An extensive range
of molecular biology tools are available, e.g., plasmids, phages, etc. Rapid
growth, inexpensive to grow and maintain, extensive range of published data
relating to this chassis, suicide mechanisms available (Wright et al., 2014).
Whole-cell metabolic models have been developed and are being improved
(Atlas et al., 2008).
Few post-translational modifications
compared to eukaryotes, e.g., reduced
protein glycosylation
Saccharomyces
cerevisiae
Glycosylation of expressed proteins. Genetically tractable and genome
sequenced. Molecular biology tools are available, e.g., plasmids
The core oligosaccharides that comprise the
protein glycosylation events in S. cerevisiae
are thought to be responsible for the
hyper-antigenic nature of proteins expressed
in this chassis rendering them potentially
unsuitable for therapeutic uses (Hamilton
and Gerngross, 2007; Cregg et al., 2009;
Walsh, 2010).
EMERGING CHASSIS
Chlamydomonas
reinhardtii
An established model organism; eukaryotic photosynthetic organism Slow cultivation time. Several strains have a
cell wall, and are therefore difficult to
transform. Low transformation frequency
due to genome integration of plasmids
Geobacillus sp. Several strains currently being developed as synthetic biology chassis including
G. thermoglucosidasius (Bartosiak-Jentys et al., 2013). Enables the application
of metabolic and enzymatic processes at higher temperatures (e.g., 55–65°C
optimum for G. thermoglucosidasius) than is possible with alternative chassis
Few biological parts have been characterized.
The majority of antimicrobial drugs are
unstable at the high temperatures that these
chassis can grow at, thus limited cloning
strategies are available.
Induced pluripotent
stem cells (iPSCs)
An ethical source of stem cells for therapeutic and other responsible innovation
applications (Cachat and Davies, 2011; Ye et al., 2013). Potential platform for
engineering complex synthetic systems across multi-tissue structures
Cellular differentiation programs are not yet
fully understood and therefore rational
engineering is difficult
Marchantia
polymorpha
Compared with other plant model organisms, this chassis has a relatively
simple, “streamlined” genomic architecture. Genome projects are underway
and several molecular biology tools are in development. Can be cultured easily
and grows rapidly (Sharma et al., 2014)
Molecular biology tools are still in
development (Chiyoda et al., 2014).
Physcomitrella
patens
An established model organism for research on plant evolution, development,
and physiology (Schaefer and Zryd, 1997; Nishiyama, 2000). Genome
sequence available. Does not have a codon usage bias
Slow growth; month timescale. Low
transformation efficiency
(Continued)
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Table 1 | Continued
Chassis Advantages Disadvantages
Pichia pastoris Higher heterologous protein expression and reduced glycosylation compared
to S. cerevisiae. Successful expression of more than 200 heterologous
proteins has been published. Proteins expressed in this chassis are thought to
be less antigenic in nature than those produced in S. cerevisiae making this
organism more suitable for therapeutic protein generation. P. pastoris is a
methylotroph, and can therefore, grow with methanol as a sole carbon source.
Can grow to high cell densities with high growth rates on inexpensive media
(Cereghino, 2000; Cregg et al., 2000; Vogl et al., 2013).
High level of clonal variation (Aw and Polizzi,
2013). Few plasmid vectors are available
Protocells Enables a complete bottom-up approach in which the cellular machinery,
metabolism, genome, etc., can all be bespoke engineered (Chen et al., 2004;
Xu et al., 2010)
Still under development
Synechocystis sp. Cyanobacteria sp. are model organisms for the study of photosynthesis, as
well as carbon and nitrogen fixation (Heidorn et al., 2011). Synthetic biology
approaches may enable coupling of photosynthesis with the generation of
biofuels and natural products (Depaoli et al., 2014). Tools are available for use in
this chassis (Heidorn et al., 2011; Berla et al., 2013).
Specialized growth conditions are required
(Berla et al., 2013)
Synthetic yeast 2.0 First designer eukaryotic genome but based on an established chassis – S.
cerevisiae. One of the first bespoke-engineered chassis, with a defined
genetic context, that has been rationally engineered for the benefit of the
synthetic biology community (Annaluru et al., 2014; Lin et al., 2014). As part of
the project, LoxPsym recombination sites are being added to the 3′ end of all
non-essential genes to allow inducible genome shuffling using a system called
SCRaMbLE (Dymond and Boeke, 2012)
The alteration of the natural genome structure
may negatively affect genome stability
Complex biosafety, biosecurity, and ethical
challenges may arise as a consequence of
alterations in the natural functions of S.
cerevisiae
Project not yet complete
POTENTIAL CHASSIS
Caenorhabditis
elegans
Genetically tractable (Redemann et al., 2011) and the genome have been
sequenced. The number and position of every cell during development are
known and therefore this organism has great potential for the engineering of
whole-organism, developmentally organized synthetic systems. Used in
synthetic screens (O’Reilly et al., 2014)
Genetic lines have to be maintained
Danio rerio Regenerative abilities. The organism is largely transparent and therefore
expression of fluorescent reporter systems can be used to characterize in vivo
synthetic systems. Established systems biology model (Mushtaq et al., 2013)
There may be alternative chasses that are
more appropriate for some applications due
to the ethical and legal considerations
associated with the use of vertebrates in
research
Drosophila
melanogaster
Genetically tractable, genome sequenced, and proven relevance to human
disease models. Drosophila-derived cell lines can be engineered for
constitutive and inducible expression of proteins (Yang and Reth, 2012)
Genetic lines have to be maintained
Xenopus tropicalis Genome sequenced. Used in synthetic screens (White et al., 2011; Tomlinson
et al., 2012).
There may be alternative chasses that are
more appropriate for some applications due
to the ethical and legal considerations
associated with the use of vertebrates in
research
engineered proteins has greatly increased the number of tools
available to synthetic biology circuit designers. The clustered,
regularly interspaced, short palindromic repeats (CRISPR)/Cas
system consists of CRISPR and CRISPR associated genes (cas)
coding for related proteins, which together constitute an adaptive
prokaryotic immune system (Barrangou et al., 2007). The CRISPR
loci consist of repeats interspaced with spacer sequences, which
are transcribed and processed into crRNAs containing individual
spacer sequences that are complementary to foreign DNA. The
crRNAs bind Cas9 nuclease and the resulting complex recognizes
and cleaves sequences complementary to the spacer sequences.
This natural system has been repurposed as a transcriptional
www.frontiersin.org November 2014 | Volume 2 | Article 60 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kelwick et al. Tools for synthetic biology
regulator by modifying the Cas proteins to deactivate nuclease
activity and creating artificial guide RNA (gRNA) sequences to
create the CRISPR interference (CRISPRi) system. Deactivated
Cas9:gRNA complexes act as repressors by binding specific sites
and inhibiting RNAP activity (Qi et al., 2013). Alternatively,
Cas9 can be fused to domains that recruit RNAP in order to
act as transcriptional activators (Bikard et al., 2013; Mali et al.,
2013).
Transcription activator-like effectors (TALEs) are proteins
secreted by Xanthomonas bacteria in order to activate expression
of plant genes during the course of infection. They consist of tan-
dem repeats of a small domain with two variable amino acid sites.
The amino acid identities of the variable sites have a simple map-
ping to the DNA base recognized, enabling chains of domains to be
stringed together in order to bind specific sequences (Boch et al.,
2009; Moscou and Bogdanove, 2009). The simple modular nature
of TALEs has enabled the engineering of synthetic proteins such as
TAL effector nucleases (TALENs) (Mahfouz et al., 2011) and arti-
ficial orthogonal activators and repressors (Morbitzer et al., 2010;
Blount et al., 2012).
Translation initiation regulators are relatively easy to de novo
design as they rely on the reasonably well-characterized thermo-
dynamics of RNA structure (Liang et al., 2011). However, unlike
transcriptional circuits, there is no common signal carrier and
thus they cannot be as easily composed into complex regulatory
designs. By repurposing a regulatory element from the tnaCAB
operon of E. coli, Liu et al. (2012), have created an adapter to
convert translational regulators into transcriptional regulators
(Liu et al., 2012). The 5′-end of the operon codes for a short
leader peptide, TnaC that stalls the ribosome in the presence of
free tryptophan. The stalled ribosome then blocks a Rho factor-
binding site located adjacent to the stop codon of tnaC, allowing
the transcription of the downstream genes tnaA and tnaB. The
ribosome-binding site of tnaC in the native operon is constitutive
but replacing this with translational regulator sequences, such as
the RNA-IN/OUT system (Ross et al., 2013), enables the control
of transcription of downstream genes.
In recent years, there has been rapid progress in developing soft-
ware algorithms to enable the design of synthetic proteins that can
be controlled at the atomic level of resolution (Leaver-Fay et al.,
2011). Computational protein design is generally split into two
components. Initially, a backbone scaffold is either artificially gen-
erated or taken from an existing known structure. Secondly, the
amino acid sequence is optimized such that it minimizes the free
energy of folding. It appears that minimizing a potential energy
function by trialing different amino acid identities and rotamers
is sufficient to achieve this. There have been a number of dra-
matic successes using this approach including the de novo design
of enzymes. The design of a novel enzyme requires knowledge
about the transition state structure of the reaction to be catalyzed
and a predicted spatial arrangement of chemical groups that are
likely to stabilize the transition state. The transition state structure
and the stabilizing constellation of chemical groups around it can
be designed theoretically (theozyme) (Tantillo et al., 1998), and
using this knowledge, known protein structures can be searched
for sites capable of accommodating side chain functional groups
in the desired geometry (Zanghellini et al., 2006). These methods
have resulted in a number of successful enzyme designs (Jiang
et al., 2008; Rothlisberger et al., 2008).
In the cell, many biochemical processes are spatially organized
in order to locally concentrate substrates or isolate toxic sub-
stances (e.g., the carboxysome or peroxisome) and reduce cross
talk between components. Efforts to engineer high-level organi-
zation in synthetic biological systems is a major challenge with
applications in encapsulating artificial organelles or protocells
(Choi and Montemagno, 2005; Agapakis et al., 2012; Hammer and
Kamat, 2012; Mali et al., 2013), the precise detection and deliv-
ery of payloads (Sukhorukov et al., 2005; Uchida et al., 2007).
Methods based on the computational protein design methods
described above have been applied to create new self-assembling
biomaterials at the atomic level from protein subunits that do
not naturally form into higher-order structures (King et al., 2012,
2014). Other work has focused on using hydrophobic patterning
of peptides to produce higher-order structures based on coiled-
coils (Rajagopal and Schneider, 2004; Woolfson and Mahmoud,
2010; Zaccai et al., 2011; Fletcher et al., 2013). However, these are
not designed to atomic level accuracy, tend to be chemically syn-
thesized and so have not yet been reported to assemble in vivo.
An alternative approach is to reuse naturally occurring protein–
protein interfaces and assemblies (Padilla et al., 2001; Howorka,
2011; Sinclair et al., 2011), although ultimately it may be more
desirable to design completely artificial protein scaffolds that are
more likely to be biologically neutral and avoid the Mullerian com-
plexity of naturally evolved biological systems (Dutton and Moser,
2011).
Novel protein biomaterials have applications in metabolic engi-
neering by co-locating enzymes in the same pathway on a struc-
tural scaffold. This has the advantage of increasing the local
concentration of substrates improving reaction kinetics, helping
to prevent the loss of intermediates to competing pathways and
the accumulation of toxic intermediates (Dueber et al., 2009).
Protein cages can be used to completely encapsulate metabolic
pathways and create synthetic bacterial micro-compartments. In
a recent example, genes from the propanediol utilization operon
(pdu) encoding for an empty protein shell in Salmonella enter-
ica were expressed in E. coli. Short peptide sequences known to
bind to pdu shell proteins were used to target pyruvate decar-
boxylase and alcohol dehydrogenase to the micro compartment
resulting in increased ethanol production (Lawrence et al., 2014).
This approach promises to be particularly useful for biosynthetic
pathways involving toxic metabolites.
Similarly, structural scaffolds can be constructed using nucleic
acids. Base pairing in nucleic acids makes predicting and designing
structures somewhat more tractable than for proteins. For exam-
ple, 2D and 3D structures have been engineered in vitro using long
single stranded DNA (ssDNA) and small ssDNA oligonucleotides
called “staples,” that direct the folding of the long ssDNA into a
pre-designed structure (Rothemund, 2006; Douglas et al., 2009;
Han et al., 2011). It has also been shown to be possible to express
simpler nanostructures in vivo using RNA transcribed by the cell
(Delebecque et al., 2011). These structures were used together with
specific protein-binding aptamers to efficiently channel substrates
from one enzyme to another and substantially increase hydro-
gen production. At short distances, substrate channeling has been
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found to be more effective than expected by simple 3D Brownian
diffusion models (Fu et al., 2012, 2014).
A number of tools for predicting and designing relative trans-
lation rates of ribosome-binding sites have been developed (Reeve
et al., 2014) including the RBS Calculator (Salis et al., 2009; Salis,
2011), the RBS Designer (Na and Lee, 2010), and the UTR Designer
(Seo et al., 2013), which can aid operon design (Arpino et al.,
2013). These software tools are based on thermodynamic models
of the pre-initiation complex of the 30S ribosomal subunit and
the messenger RNA (mRNA) and include terms based on the free
energy required to unfold the unbound mRNA, the free energy
of hybridization of the mRNA and the 16S rRNA, and various
other terms. If the pool of free 30S ribosomal subunits is assumed
to be roughly constant then the translation initiation rate can
be assumed to be proportional to exp(−β∆G). Mechanistic pre-
dictive models for promoters are somewhat more complicated as
promoter strength is related to the binding of the sigma factor and
RNAP, and also the efficiency of promoter escape. However, there
has been some success in predicting the strength of promoters for
the E. coli sigma factor σE using relatively simple position weight
matrix models (Rhodius and Mutalik, 2010; Rhodius et al., 2012).
Most of the synthetic regulatory tools described above are
used in the construction of transcriptional circuits. Neverthe-
less, post-transcriptional circuit design, particularly using RNA
molecules, has attracted a great deal of interest in recent years
(Liang et al., 2011; Wittmann and Suess, 2012). Unlike proteins,
RNA molecules are somewhat easier to design due to their well-
understood thermodynamics and the dominance of secondary
structure formation on folding. One important application area
is the use of RNA as switches (riboswitches) that respond to their
environment. Riboswitches are RNA molecules that can regulate
protein production in response to changes in the concentration
of a small molecule and occur naturally as well as being syn-
thetically designed. These molecules are composed of an RNA
aptamer that binds a specific small-molecule ligand. On binding
the small molecule, the RNA aptamer may then change confor-
mation resulting in either the occlusion of the Shine–Dalgarno
sequence or its increased accessibility. Expression of the down-
stream genes is then turned either on or off in response (Suess
et al., 2004). Alternatively, aptamers may be coupled to a ribozyme
that allosterically cleaves itself in response to ligand binding (Tang
and Breaker, 1997; Penchovsky and Breaker, 2005). The de novo
design of small-molecule binding RNA aptamers is a non-trivial
task but novel aptamers can be evolved in vitro using methods
such as SELEX (systematic evolution of ligands by exponential
enrichment) (Ellington and Szostak, 1990; Tuerk and Gold, 1990;
Jenison et al., 1994). Riboswitches may have uses in metabolic
engineering such as down-regulating upstream genes if a metabo-
lite reaches toxic levels (Zhang and Keasling, 2011). RNA aptamers
have also found use as mimics of GFP by binding small-molecule
fluorophores (Paige et al., 2011). As discussed in the metrology
section, these aptamers can be used to monitor mRNA levels.
BIOPART CHARACTERIZATION
Biopart characterization describes the functional and experimen-
tal metadata that is required to sufficiently capture the biological
behavior of a biopart and the context in which it is being tested.
The type and range of these characterization data have evolved
over time as highlighted by refinements in biopart characteri-
zation data sheets (Arkin, 2008; Canton et al., 2008). Typically,
these experimental metadata include information on the plas-
mid vector, the testing organism or strain, any relevant growth
conditions, and the equipment or methodologies used to capture
the bioparts functionality. The primary purpose of biopart char-
acterization data is to provide the necessary experimental data
for predictive in silico biological modeling. The determination
of which biological data provide0 the greatest insight into the
behavior of a given biological system is largely debatable; at least
until more biological design rules are understood. The context
dependency of bioparts in vivo provides significant challenges in
predicting their function as modular components. Therefore, for
biopart characterization, measurement standards should largely
be defined by those biological data that can be measured (metrol-
ogy), how relevant those data are for predicting the behavior of a
biological process (modeling) and how widely these data can be
adopted (standardization). This last point is particularly impor-
tant since bioparts should ideally be reusable (modular) across
multiple applications and contexts. To enable this, the formatting
of these data should ideally be standardized to facilitate the mea-
surement and use of biopart characterization data across different
in silico design tools, forward-design strategies, and workflows.
The most concerted effort is the Synthetic Biology Open Lan-
guage (SBOL) consortia, a group of life scientists, engineers,
computer scientists and mathematicians that are actively build-
ing a set of standards that define a common data format for
bioparts and their accompanying characterization data (Bower
et al., 2010; Galdzicki et al., 2011; Quinn et al., 2013; Roehner and
Myers, 2013). The concept is to create a file structure that can
capture biopart sequence, characterization and experimental data
in a format that is platform independent. Crucially, the format
is designed to be extendable to include additional parameters as
new characterization technologies and methodologies emerge. In
combination with SBOL visual (SBOLv),which defines a standard-
ized way to visually denote bioparts through symbols, the SBOL
standard is set to enable the seamless sharing of genetic designs.
Several bioinformatics and molecular cloning design tools have
already adopted SBOL, and the intention for SBOL is to provide
an interoperable standard between several in silico tools such that
individuals can optimize their workflow as required, yet retain
information between them. Several of these in silico tools have
been extensively reviewed (MacDonald et al., 2011; Galdzicki et al.,
2014); however, we include an updated list here, that combines
in silico tools from these existing reviews, along with several new
tools, in particular R2o designer and COOL (Table 2).
In contrast to SBOL, which is still under development, the
iGEM registry of standard biological parts (http://parts.igem.org/)
has provided a relatively large-scale and publically accessible repos-
itory of bioparts and some biopart characterization data for almost
10 years. Since its inception, the iGEM community has led, with
mixed success, concerted efforts to improve the quality of its
characterization data. The 2014 iGEM competition, for instance,
has announced several specialist awards for teams that demon-
strate advancements in metrology. This push for improvements in
biopart characterization at the grassroots (undergraduate) level
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Table 2 | Emerging tools for the forward-design of synthetic pathways and systems.
Software tool Description
PATHWAYAND CIRCUIT DESIGN
AutoBioCAD Automated design of gene regulatory circuits (Rodrigo and Jaramillo, 2013).
Cell designer Modeling of biochemical networks. http://www.celldesigner.org/
Genetic engineering
of cells (GEC)
Biological programing language and visual simulator of biological systems. http://research.microsoft.com/en-us/projects/gec/
GenoCAD GenoCAD is an open-source computer-assisted-design (CAD) application for synthetic biology. http://www.genocad.org/
Genome compiler –
iGEM edition
Cloud based genetic design tool that is optimized for BioBrick assembly and the iGEM competition.
http://igem.genomecompiler.com/join
MATLAB: Simbiology SimBiology® provides an application and programmatic tools to model, simulate, and analyze dynamic biological systems.
http://www.mathworks.co.uk/products/simbiology/
Operon calculator Rational design of bacterial operons to control protein expression.
https://salis.psu.edu/software/OperonCalculator_EvaluateMode
OptCom A modeling framework for the flux balance analysis of microbial communities. http://maranas.che.psu.edu/software.htm
ProMoT Process Modeling Tool, software for the construction and manipulation of complex technical and biological systems.
http://www.mpi-magdeburg.mpg.de/projects/promot/
BIOPART DESIGN
CaDNAno Simplifies the process of designing three-dimensional DNA origami nanostructures. http://caDNAno.org/
COOL Codon Optimization OnLine (COOL): a web-based multi-objective optimization platform for synthetic gene design (Chin et al.,
2014)
mfold/UNAfold Prediction of nucleic acid secondary structure (Markham and Zuker, 2008). http://mfold.rna.albany.edu/
NUPAC Prediction and design of nucleic acid secondary structure (Zadeh et al., 2011). http://www.nupack.org/
Promoter calculator E. coli σE – In development (Rhodius and Mutalik, 2010; Rhodius et al., 2012).
RBS calculator The Ribosome-Binding Site (RBS) Calculator is a design method for predicting and controlling translation initiation and protein
expression in bacteria. https://salis.psu.edu/software
RBS designer Computational design of synthetic ribosome-binding sites (RBS) to control gene expression levels.
http://ssbio.cau.ac.kr/web/?page_id=195
RNA designer Designs RNA secondary structure (Andronescu et al., 2004). http://www.rnasoft.ca/cgi-bin/RNAsoft/RNAdesigner/rnadesign.pl
Rosetta Tools for structure prediction, design, and remodeling of proteins and nucleic acids. http://maranas.che.psu.edu/software.htm
UTR designer Predictive design of mRNA translation initiation region to control prokaryotic translation efficiency (Seo et al., 2013).
http://sbi.postech.ac.kr/utr_designer
MISCELLANEOUS
R2oDNA designer Designs orthogonal biologically neutral linker sequences for DNA assembly and other uses (Casini et al., 2013, 2014).
http://r2oDNA.com/
SBOL SBOL core provides an interoperable data format to transfer biopart characterization data between software programs and
tools (Roehner and Myers, 2013). http://www.sbolstandard.org/
SBOLv SBOL visual defines a standardized way to visually denote bioparts through symbols (Quinn et al., 2013).
http://www.sbolstandard.org/visual
has permeated up to professional characterization efforts. For
instance, early difficulties in the reproducibility of the behavior
of DNA regulatory elements between iGEM teams and profes-
sional research groups provided the context for the emergence of
the relative promoter unit (RPU) as a reference measurement stan-
dard (Kelly et al., 2009). The RPU standard compares the relative
activity of a promoter against a reference standard, tested under
the same experimental conditions, with an RPU arbitrarily set
to 1. The rationale underpinning this standard is that while the
absolute activity of a promoter may differ between experimental
repeats, the relative activity should be less prone to such vari-
ability. Essentially, a promoter that is twice the strength of the
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standard should remain so, even between different experimen-
tal conditions and methodologies of different research groups. In
agreement with this, Kelly et al. (2009) reported a 50% decrease
in variability, when RPUs were independently reported for a set
of Anderson constitutive promoters. Inter-experimental variabil-
ity and reproducibility of data are a significant problem facing all
scientific endeavors (Collins and Tabak, 2014), and for synthetic
biologists the RPU measurement standard has highlighted these
issues within the context of biopart characterization.
There are, however, no universally agreed standards for advanc-
ing biopart characterization metrology, though in general the field
is shifting away from relative measurements toward absolute mea-
surements (Table 3). Many research groups are currently interested
in measuring absolute numbers of cells, DNA molecules, proteins,
or other components that constitute the synthetic system and its
context. But this shift is largely incremental as certain types of bio-
logical data are very difficult to measure directly. These challenges
are, however, worth addressing since it is assumed that such bio-
logical data are essential to improve the predictive capabilities of
forward-design in silico models (Bower et al., 2010; Cooling et al.,
2010). Yet, because of such data limitations, current-modeling
approaches often depend upon inferred or assumed parameters
that are derived from biological data that can be experimentally
verified. One such modeling approach by Canton et al. (2008),
proposed a set of standardized measurement units termed, PoPs
and ribosomes per second (RIPS), even though the absolute bio-
logical data that underpin them has not been directly measured
in vivo (Canton et al., 2008; Cooling et al., 2010; Marchisio, 2014).
PoPs infers the flow of RNAP along a point of DNA per second
and RIPS infers the flow of ribosomes across an mRNA molecule.
As previously noted, PoPs and RIPS cannot be measured directly;
instead they are calculated using fluorescence data from a reporter
protein (e.g., GFP), growth data (OD), and largely assumed values
for other parameters including protein or mRNA concentrations.
These data are generally measured in vivo within a plate reader
setup, though flow cytometry-based characterization efforts are
increasingly being adopted and are set to progress metrology at
the single cell level (Díaz et al., 2010; Tracy et al., 2010; Choi et al.,
2013; Zuleta et al., 2014). In either case, if experimental setups are
sufficiently standardized, it is possible to convert measurements
between several widely adopted standards: RPU, PoPs/RIPS, and
absolute measurements such as GFP cell−1 s−1 (Kelly et al., 2009).
Notwithstanding the above limitations of PoPs and RIPS, these
units were primarily designed to reflect the behavior of genetic
circuits at the level of information flow (inputs/outputs) rather
than at the truly mechanistic level (Gardner et al., 2000; Canton
et al., 2008; Stricker et al., 2008; Marchisio, 2014). For biologists,
however, these terms represent an abstract merger of several ele-
ments of the transcriptional and translational machinery, which
does not accurately reflect the mechanistic underpinning biol-
ogy. However, abstract and mechanistic modeling approaches are
not necessarily mutually exclusive since both approaches can pro-
vide insightful information for the forward-design of predictable
biological pathways and systems.
Advances in metrology and novel measurement standards that
are accessible, and hence, more widely adopted will clearly benefit
the whole field of synthetic biology. Yet, it is challenging to achieve
consensus for developing measurement standards, since standards
intrinsically empower those that promote them above those that
have not adopted them (Calvert, 2012; Frow and Calvert, 2013).
Conversely, it should be noted that consensus in measurement
standards and metrology does not preclude innovation if such
standards are flexible enough to accommodate developments in
the tools and methodologies that enable researchers to easily share,
reuse, and build upon existing genetic designs. Likewise, stan-
dardized biological information can still be combined with expert
knowledge, or novel forward-design strategies for the construction
of complex, robust, and efficient biological systems.
Metrology in biology has been enabled in part to con-
tinual advancements in microscopy and in synthetic biology,
Table 3 | Synthetic biology measurement standards.
Measurement standard Advantages Disadvantages
RELATIVE
Relative promoter unit
(RPU)
Reduces variability between promoter characterization
data across different laboratory groups, equipment or
slightly different experimental protocols.
The choice of reference standard promoter requires consensus
Concept may be applied in other contexts beyond
promoter characterization.
ABSTRACT
Polymerase operations
per second (PoPs) and
ribosomes per second
(RIPS)
Describes information flow (input/output) from
transcriptional-based logic devices
Units cannot be directly measured
May not capture biological processes at the mechanistic level
Abstract level modeling Does not describe biological information that is sent through
other mechanisms e.g., protein post-translational modifications
ABSOLUTE
GFP cell−1s−1 Direct measurement of the number of fluorescent
reporter proteins produced
Requires careful consideration of the design and measurement
of the calibration curve needed to compare fluorescence
(arbitrary units) and known fluorescent protein concentrationsDirect comparisons can be made between data sets
Concept may be applied to other biological reporters
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technologies such as microfluidics coupled with quantitative
microscopy are continuing to gain traction (Lin and Levchenko,
2012; Song et al., 2013; Walter and Bustamante, 2014). Microflu-
idic technologies enable the precise manipulation of fluids at
small-scales through engineered channels, chambers, and valves.
Microfluidic chip designs are sufficiently advanced to enable a
high-degree of spatial-temporal control of liquid-flows to and
between individual cells or cell populations seeded within the
chambers of prefabricated microfluidics chips. With this level of
control, small molecules that induce gene expression or influence
other biological processes can be precisely delivered to elicit acute,
basal, or morphogenic responses. Within a synthetic biology con-
text, such systems have been used to characterize DNA regulatory
elements, intercellular communication, and synthetic pathways at
high spatial–temporal resolution. One notable example shown by
Hansen and O’Shea (2013), in which the microfluidic control of
the delivery of a small molecule (1-NM-PP1) was used to control
the nuclear localization of a Yeast stress-inducible transcription
factor, Msn2. Deliberate alterations in the oscillatory or acute
dynamics of Msn2 trans-nuclear localization revealed the extent to
which promoters respond differently to transcriptional-activation
dynamics. From this, promoters could be modeled in silico, accord-
ing to the extent that they could elicit differential gene expression
patterns, as a consequence of their ability to distinguish a gen-
uine nuclear-influx of Msn2 from background “noise” (Hansen
and O’Shea, 2013). Manipulation of these dynamics could be used
to reduce promoter leakiness; or conversely to exploit different
classes of promoter transcriptional-signal processing to coordinate
multiple genetic programs, through the modulation of a single
transcription factor.
Another important technology for synthetic biology is flow
cytometry, which relies upon hydrodynamic focusing to guide
single cells through a fluidic channel where they are measured
(Piyasena and Graves, 2014). Recent models of flow cytometers
can simultaneously measure cell size, complexity, and up to 17
channels of fluorescence (Basiji et al., 2007; Piyasena and Graves,
2014), each of which could be used to capture data from differ-
ent reporter outputs. Of the biological reporters available, RNA
aptamers are particularly noteworthy, since they have the potential
to increase the type and range of biological information that can be
measured (Cho et al., 2013; Pothoulakis et al., 2014). For instance,
several groups have reported the simultaneous measurement of
both transcription (mRNA levels) and translation (protein levels)
(Chizzolini et al., 2013; Pothoulakis et al., 2014). In both cases
Spinach, an RNA aptamer that binds a fluorophore (Paige et al.,
2011), was incorporated within the 3′ untranslated region (UTR)
of a fluorescent reporter protein, either GFP or RFP (Chizzolini
et al., 2013; Pothoulakis et al., 2014). Providing there is no spectral-
overlap between fluorophores, this strategy could conceivably be
up-scaled to measure entire synthetic pathways, and thus inform
operon design strategies (Hiroe et al., 2012; Chizzolini et al., 2013).
Metabolic engineering efforts may also benefit from engineered
RNA aptamer-hybrids that simultaneously bind cellular metabo-
lites and a fluorophore, effectively enabling the real-time reporting
of intracellular metabolic flux (Barrick and Breaker, 2007; Roth
and Breaker, 2009; Sefah et al., 2013; Szeto et al., 2014). These
exponential increases in biological data could significantly impact
whole-cell modeling (Atlas et al., 2008; Gama-Castro et al., 2011;
Shuler et al., 2012; O’Brien et al., 2013) and pave the way for novel
measurement standards or modeling approaches that are wholly
based upon directly measured biological processes.
ASSEMBLING DNA INTO BIOPARTS, PATHWAYS, AND
GENOMES
Recombinant DNA technology, in which DNA sequences are “cut
and pasted” together via restriction enzymes and DNA ligases
respectively, form the foundations of the 1970s biotechnological
revolution and have greatly expanded the possibilities of genetic
engineering (Zimmerman et al., 1967; Cohen et al., 1973; Lob-
ban and Kaiser, 1973). Synthetic biology continues to benefit
from these foundational advancements in recombinant DNA-
based biotechnology. For example, the BioBrick DNA assembly
standard, uses a set of standardized restriction sites, termed the
prefix (EcoRI XbaI) and suffix (SpeI Pst I), that flank each biopart
(BioBrick) (Rokke et al., 2014). Digestion and ligation using these
sites allow several parts to be assembled together in a standard
fashion. The BioBrick standard was originally developed by Tom
Knight in 2003 and is still used within the synthetic biology com-
munity, particularly during the iGEM competition (Rokke et al.,
2014). The BioBrick assembly standard is beneficial to the syn-
thetic biology community for several reasons. Firstly, the flanking
restriction site sequences set a physical border that defines individ-
ual bioparts. As a result, the BioBrick assembly standard realizes
the idea that DNA sequences encode discrete functions and that
these individual blocks (BioBricks) can be assembled together like
“legotm bricks.” Additionally, the use of standardized restriction
sites ensures that the cloning strategy for assembling BioBricks is
standardized across the entire research community; thereby elim-
inating the requirement for some cloning-based tacit knowledge.
Despite these advantages, a major limitation of the approach is
that BioBrick sequences must not contain the prefix and suffix
restriction sites, thus limiting the range of sequences that can
be assembled. Additionally, when XbaI and SpeI sites are ligated
together, the ligated sequence creates a “scar,” which does not con-
tain either an XbaI or SpeI restriction site (Speer and Richard,
2011; Rokke et al., 2014). Scar sequences may alter the behavior of
the flanking bioparts or prevent the generation of fusion proteins,
and therefore, can be undesirable (Anderson et al., 2010; Ellis et al.,
2011).
BioBrick assembly is also an inefficient way to create large
multi-part constructs since it is limited to the assembly of two
bioparts per reaction, as defined by the three antibiotic (3A)
assembly method (Speer and Richard, 2011). ePathBrick poten-
tially overcomes this limitation through the use of an expansive
set of BioBrick-compatible isocaudomer pairs of restriction sites
(Xu et al., 2012). The combinatorial assembly of multiple inserts
is possible through the restriction digestion and ligation of dif-
ferent isocaudomer pairs into an ePathBrick vector. Backwards
compatibility with the BioBrick standard is certainly advanta-
geous from the perspective of modularity (re-useable bioparts);
however, ePathBrick is still subject to the BioBrick limitations of
forbidden sequences and post-assembly scar sequences. With these
limitations in mind, several DNA assembly methods have been
developed to address them (Figure 2) (Chao et al., 2014).
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FIGURE 2 | DNA assembly strategies. Restriction enzyme – restriction
enzymes recognize specific DNA sequences and either cut within their
recognition sequence (Type II) or adjacent to its recognition sequence (Type
IIS) to create sticky or blunt-ended DNA fragments that can be ligated to
other DNA fragments. Recombination – cellular DNA repair and
recombination machinery can be utilized to integrate a DNA construct within a
specific genomic locus. Integration is guided through 5′ and 3′ sequence
complementarity of the integration sequence with the target locus.
Overlap-directed – assembly order is guided by 20–40 bp overlaps at the ends
of each DNA fragment that share sequence homology with adjacent DNA
fragments. In the case of Gibson assembly, these homologous ends are
processed (chew-back) and fused together (anneal) via the sequential activity
of an exonuclease, a ligase, and a polymerase. DNA synthesis – DNA
sequences are designed and optimized in silico for de novo synthesis.
Commercial constructs are delivered as gene fragments or are pre-cloned
within a plasmid vector.
RESTRICTION-DIRECTED ASSEMBLY: Bgl BRICKS, GOLDEN GATE, AND
SEVA
Golden gate assembly (Engler et al., 2008; Engler and Marillonnet,
2011, 2013), Bgl Bricks (Anderson et al., 2010), and the Standard
EuropeanVector Architecture (SEVA) (Silva-Rocha et al., 2013) use
a set of restriction sites to standardize DNA assembly. However, in
contrast to the BioBrick standard, these assembly methods use rare
restriction site sequences, and therefore, support a greater range of
sequences. The Bgl Brick standard uses BglII and BamHI restric-
tion sites. Annealed BglII and BamHI restriction sites generate an
inert, glycine-serine encoding scar sequence, which in contrast to
the BioBrick standard scar allows the assembly of protein fusions.
Golden Gate assembly supports scar-less assembly through the
use of Type IIS restriction enzymes that act by cleaving outside
of their recognition sequence leaving a variable overhang, which
directs the assembly order and ligation reaction. If cleavage sites
are designed appropriately, these overhangs can be designed so that
the final assembled sequences are “scar-less.” More recently, com-
binatorial Golden Gate assembly methods have been described
that allow multi-gene constructs, including synthetic pathways,
to be assembled in parallel (Engler and Marillonnet, 2011, 2013).
SEVA and to some extent ePathBrick, differ from the majority
of assembly methods in that they are more correctly described as
modular standards. SEVA describes a set of criteria for the physical
assembly of plasmids according to a three-component architec-
ture: an origin of replication segment, a selection marker segment,
and a cargo segment (Silva-Rocha et al., 2013). These segments are
flanked by insulator sequences and assembled together with a set of
rare restriction sites. While the rationales for restriction site-based
assembly methods support modularity, their limitations have led
several research groups in the synthetic biology community to
“trade-in” standardization and modularity, in favor of “bespoke”
assembly methods that enable one-pot assembly of multiple DNA
parts.
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OVERLAP-DIRECTED ASSEMBLY: GIBSON, SLiC, CPEC, SLiCE, AND
PAPERCLIP
Daniel Gibson developed a widely adopted DNA assembly method
that allows multiple DNA fragments to be assembled in a one-
pot in vitro reaction (Gibson et al., 2009; Gibson, 2011). The
Gibson assembly uses a linearized destination vector and PCR
generated inserts as its starting material. Inserts are generated with
PCR primers that include 20–40 bp overlaps that share sequence
homology to adjacent DNA fragments. As a result, the correct
arrangement of several inserts entering the same destination vec-
tor can be defined. During the reaction, a T5 exonuclease acts to
chew-back at the 5′ ends of the linearized destination vector and
inserts. The reaction occurs at 50°C and therefore the T5 exonucle-
ase along with its activity is eventually inactivated. The destination
vector and inserts anneal together, as defined by their exonuclease
exposed homologous ends, and Phusion polymerase activity acts
to fill in the gaps. Finally, Taq ligase seals nicks between the joined
DNA fragments. Gibson assembly is simple, can assemble five or
more parts in a single reaction, and the reaction itself only takes
around 60 min, after which the final assembled product can be
directly transformed into E. coli.
Sequence and Ligase-independent Cloning (SLiC) (Li and
Elledge, 2007), Circular Polymerase Extension Cloning (CPEC)
(Quan and Tian, 2009, 2011), Seamless Ligation Cloning Extract
(SLiCE) (Zhang et al., 2012) are also overlap-directed DNA assem-
bly methods that all result in the same final product. Therefore,
inserts and destination vectors designed for Gibson assembly can
also be used in SLiC, CPEC, and SLiCE assemblies. During SLiC
reactions, the destination vector and inserts are independently
treated in vitro with T4 DNA polymerase, which exhibits exonu-
clease activity in the absence of deoxynucleotide triphosphates
(dNTPs). Exonuclease activity is subsequently inhibited with the
addition of deoxycytidine triphosphate (dCTP) and the destina-
tion vector and inserts are then mixed together for annealing.
However, because SLiC reactions do not include DNA ligase, gaps,
or nicks in the DNA are repaired once the final product is trans-
formed into E. coli. CPEC on the other hand, is a PCR-based
approach in which the linearized destination vector and inserts
are initially denatured to produce single DNA strands. These are
then annealed together, as directed by the homologous DNA over-
lap regions. Once annealed, the destination vector and inserts act
to prime each other for extension via the activity of Phusion DNA
polymerase. A low number of PCR cycles act to prevent the propa-
gation of PCR-based errors. SLiCE reactions markedly differ from
the assembly methods just described in that they involve an ex
vivo bacterial cell extract (PPY, E. coli DH10B λ–red) as the reac-
tion mix. Since exogenous polymerases and DNA ligases are not
required, this is a potentially cost-effective method and like Gib-
son, assembly reactions also typically take just 60 min, although at
37°C instead of 50°C as per Gibson assembly.
PaperClip DNA assembly is a relatively new overlap-directed
assembly method that uses pairs of bridging oligonucleotides
termed “Clips” to direct the assembly of multi-part con-
structs (Trubitsyna et al., 2014). Interestingly, PaperClip assembly
protocols are derived from CPEC (PCR-based) and SLiCE (ex
vivo-based) assembly methodologies. Yet, PaperClip assembly is
advantageous over these assembly methods in that once the“Clips”
have been prepared, the required assembly order of parts can be
determined in a single reaction. While, “Clips” introduce an ala-
nine encoding scar sequence between each part, the bridging oligos
used to assemble multi-part constructs in ligase cycling reaction
(LCR) assembly are scar-less (Rouillard et al., 2004; de Kok et al.,
2014). Though as we describe below, PaperClip assembly dif-
ferentiates itself from Gibson, CPEC, SLiCE, and LCR assembly
methods in that de novo assembly fragments do not need to be
generated each time the order assembly is changed (Trubitsyna
et al., 2014).
Overlap-directed assembly methods use sequence homology to
guide assembly and are therefore largely sequence independent.
This is a clear advantage over restriction site-based DNA assembly
methods and their forbidden sequences. It should be noted that
repeat and short DNA sequences, particularly those that give rise
to DNA secondary structures, can reduce the efficiency of overlap-
directed methods and are best avoided. On the other hand, CPEC
denaturation PCR cycles mitigate the effect of DNA secondary
structures to some degree. Overlap-directed methods are also effi-
cient at assembling multiple parts in a predefined order within a
single one-pot reaction. Gibson assembly, for example, has been
used to assemble genome-scale DNA fragments, including the
complete assembly of the M. genitalium genome (583 kb) and
more recently the entire mouse mitochondrial genome (16.3 kb)
(Gibson et al., 2008, 2010b). It is clear therefore that overlap-
directed assembly methods can be scaled toward the assembly
of large genetic constructs, including synthetic genomes (Gibson
et al., 2010a). Yet, despite their proven utility, they are inherently
“bespoke” and are thus in conflict with the ideals of embedding
standardization and modularity concepts within DNA assembly
strategies. For instance, custom primers are needed to generate
inserts de novo each time the assembly order is changed and while
it is now possible to automate overlap-directed assembly primer
design (Hillson et al., 2012), these assembly methods still require
tacit knowledge. To this end, additional methodologies are being
developed with the aim of making overlap-directed DNA assembly
modular.
OVERLAP-DIRECTED ASSEMBLY WITH BIOLOGICALLY NEUTRAL LINKER
SEQUENCES
Modular overlap-directed assembly with linkers (MODAL) makes
use of standardized flanking sequences and biologically neutral
(orthogonal) linkers as part of a modular overlap-directed DNA
assembly strategy (Casini et al., 2013). MODAL assembly requires
bioparts to be standardized with the addition of a common prefix
and suffix sequence. The prefix and suffix sequences do not con-
tain restriction sites and are not directly required for the assembly
process. Instead, these sequences serve as a consistent set of PCR
primer “landing pads” that enable all MODAL bioparts to be gen-
erated using the same primer set. Additionally, these sites serve as
priming sites for the PCR-directed addition of biologically neutral
linker sequences that serve as homologous sequences for overlap-
directed assembly. These sequences can be designed with R2oDNA
Designer (Casini et al., 2013, 2014), an in silico tool that was
developed to automatically design orthogonal linker sequences
for use in MODAL and other applications. Similar strategies have
also been developed in parallel, in which biologically inactive
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unique nucleotide sequences (UNSes) were utilized to guide the
Gibson assembly of insulated genetic circuits (Guye et al., 2013;
Torella et al., 2014a,b). These neutral sequences are often stan-
dardized and may also incorporate BioBrick restriction sites, thus
enabling modularity and standardization to be embedded within
overlap-directed assembly strategies.
IN VIVO DNA ASSEMBLY AND GENOME ENGINEERING
An array of chassis with a broad set of useful, extensively char-
acterized genotypes and phenotypes are available to the synthetic
biology community (Table 2). However, there are applications
where it is appropriate to rationally engineer a chassis. For instance,
an application may require a novel strain that is optimized, at
the genome level, to fit a set of specific design requirements that
may be difficult or otherwise impractical to bioprospect. Typi-
cally, genome-engineering efforts are geared toward maximizing
compatibility between a chassis and a synthetic system, increasing
the efficiency of the metabolic flux across a synthetic pathway or
toward minimizing burden effects. The field is making progress
in establishing rationally engineered genomes; of which the syn-
thetic yeast 2.0 project (Dymond and Boeke, 2012; Annaluru et al.,
2014; Lin et al., 2014) and minimal genome projects (Glass et al.,
2006; Dewall and Cheng, 2011; Shuler et al., 2012), are currently
the most prominent exemplars. These genome-engineering efforts
are made possible due to the emergence and ongoing develop-
ment of an expanding set of in vivo DNA assembly methods and
genome-engineering tools.
Recombineering approaches, in which synthetic linear
ds/ssDNA sequences are introduced into genomic regions through
a process of homologous recombination, have proven utility as
an efficient method to knockout or knock-in sequences of inter-
est. Recombineering enables genomic engineering at all scales;
from the introduction of single nucleotide polymorphisms, to
the replacement of 40 kb+ DNA fragments or even toward the
assembly of entire genomes (Narayanan and Chen, 2011; Zhao
et al., 2011; Bonde et al., 2014; Song et al., 2014). S. cerevisiae
transformation-associated recombination (TAR) cloning (Koup-
rina and Larionov, 2008), Bacillus Domino (Ohtani et al., 2012),
and the E. coli Single-Selective-Marker Recombination Assembly
System (SRAS) (Shi et al., 2013) uses the endogenous homologous
recombination machinery of the indicated organisms to assemble
DNA constructs in vivo. A variant of the yeast TAR method has
successfully generated several genomes, including the first in vivo
assembled synthetic genome of M. genitalium (Gibson et al., 2008).
Bacillus domino has also shared similar successes in that this
assembly method has also assembled DNA at the genomic scale,
including the mouse mitochondrial genome and the rice chloro-
plast genome (Itaya et al., 2008; Ohtani et al., 2012; Iwata et al.,
2013). While E. coli SRAS could potentially support the assembly
of large DNA fragments, it is currently optimized for the assembly
of multi-part constructs and their simultaneous integration into
the E. coli genome (Shi et al., 2013).
The lambda-red (λ-red) recombinase system is another recom-
bineering strategy, which is used for the integration of ssDNA
or dsDNA constructs into the E. coli genome (Murphy, 1998;
Murphy and Campellone, 2003). Optimized lambda-red recom-
bination protocols can integrate linear DNA sequences into a
specific genomic target, guided by only 35–50 bases of flanking
homologous sequence (Murphy and Campellone, 2003). Interest-
ingly, lambda-red-mediated recombination events do not require
endogenous recombination proteins (e.g., RecA) and instead lin-
ear ssDNA or dsDNA constructs are integrated into the E. coli
genome via the action of three λ-red proteins; Gam, Exo, and
Beta. Gam protects linear dsDNA from the exonuclease activity of
the endogenous proteins RecBCD, thus increasing the efficiency at
which the introduced dsDNA will be recombined into the genome.
λ-red-mediated recombination itself is primarily mediated by Exo,
a 5′–3′ – dsDNA-specific exonuclease and Beta, a ssDNA annealing
protein. It is interesting to note that Gam-associated protection of
dsDNA is exploited in SLiCE ex vivo DNA assembly and as we
discuss later, for in vitro transcription–translation (TX–TL) cou-
pled reactions involving linear DNA as the input (Sitaraman et al.,
2004).
The introduction of a large number of rationally engineered
genomic changes is a potentially laborious process; however,
multiplex automated genome engineering (MAGE) enables the
automation of large-scale recombineering strategies. MAGE was
originally characterized within EcNR2, a variant strain of E. coli
MG1655. EcNR2 was modified to incorporate the λ-red recombi-
nation system and also to be deficient in DNA mismatch repair via
the knockout of the mutS gene (Wang et al., 2009). MAGE relies
upon the λ-red Beta protein-assisted incorporation of ssDNA
oligonucleotides, typically 90mers, into the lagging strand dur-
ing DNA replication (Wang et al., 2009). MAGE oligonucleotide
pools can be designed to incorporate highly specific changes at a
single genomic site, to introduce multiple changes across a single
locus or to simultaneously target multiple genomic sites. These
outcomes are largely defined through the diversity of the MAGE
oligonucleotide pool, where mixtures of degenerate oligonu-
cleotides can be designed to introduce divergent changes across
a broad sequence and recombination efficiency space. Where a
large number of simultaneous genomic changes are required, the
process can be repeated through multiple MAGE cycles of cell
growth, electroporation of oligonucleotides into the cell popula-
tion, and phenotype/genotype characterization. MAGE cycles can
be automated through a microfluidics-type setup and in combi-
nation with MODEST or optMAGE, which are in silico MAGE
oligonucleotide design tools (Table 4), the directed evolution of a
rationally designed chassis, can be accomplished within a timescale
of several days. Indeed, MAGE has been used to optimize the DXP
pathway in E. coli, such that isolated variants that are capable of
a fivefold increase in lycopene production were engineered in just
3 days (Wang et al., 2009).
In parallel with MAGE, conjugative assembly genome engi-
neering (CAGE) can be used to coordinate large-scale genomic
engineering strategies across phases, such that subtle genetic com-
binations that are lethal can be screened out in a manner that
does not impede overall progress toward the final strain. To
achieve this, CAGE guides the conjugal transfer of MAGE genome
modifications between hierarchical pairs of donor–recipient E.
coli, such that a new strain emerges which incorporates all of
the MAGE-optimized modifications from previous generations
(Isaacs et al., 2011). Multiple MAGE–CAGE rounds enable a
large set of genomic modifications to be generated and carefully
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Table 4 | DNA assembly and genome-engineering tools.
Assembly
method
Mechanism Sequence independent* Scar-less
assembly
Software support tools
Bgl Brick Type II restriction
enzymes
No No Under development
BioBrick
standard
Type II restriction
enzymes
No No Registry of standard biological parts, an
online and physical repository of BioBrick
parts (http://parts.igem.org/)
ePathBrick Type II restriction
enzymes
No No –
SEVA Type II restriction
enzymes
No Possible SEVA-DB platform, an online repository of
SEVA-compliant parts (Silva-Rocha et al.,
2013)
Golden gate Type IIS restriction
enzymes
No Possible j5, an automated primer design tool can be
adapted for Golden gate combinatorial
assembly (Hillson et al., 2012)
Gibson Overlap-directed Yes – however, short or repeat
sequences that give rise to secondary
DNA structures are a problem
Yes j5, an automated primer design tool (Hillson
et al., 2012)
SLiC Overlap-directed Yes – however, short or repeat
sequences that give rise to secondary
DNA structures are a problem
Yes j5, an automated primer design tool (Hillson
et al., 2012)
CPEC PCR-based
overlap-directed
Yes – however, short or repeat
sequences are a problem
Yes j5, an automated primer design tool (Hillson
et al., 2012)
SLiCE Ex vivo
overlap-directed
Yes – however, short or repeat
sequences that give rise to secondary
DNA structures are a problem
Yes j5, an automated primer design tool (Hillson
et al., 2012)
PaperClip Overlap-directed
with oligonucleotide
pairs “Clips”
Yes – however, constructs cannot
contain repetitive parts or more than
40 bases of identical regions
No –
Ligase cycling
reaction
Bridging
oligo-directed
assembly
Yes Yes Gene2Oligo: oligonucleotide design for
in vitro gene synthesis (Rouillard et al., 2004).
http://berry.engin.umich.edu/gene2oligo/
Gibson with
UNSes
Overlap-directed
with orthogonal
linkers
Yes No R2oDNA designer: computational design of
biologically neutral (orthogonal) synthetic
DNA sequences (Casini et al., 2013, 2014).
Computational design rules for UNSes (Guye
et al., 2013; Torella et al., 2014a,b).
MODAL Overlap-directed
with orthogonal
linkers
No No R2oDNA designer: computational design of
biologically neutral (orthogonal) synthetic
DNA sequences (Casini et al., 2013, 2014).
Bacillus
domino
In vivo homologous
recombination
Yes – however, cannot assemble
Bacillus genomic sequences
Yes –
E. coli (SRAS) In vivo homologous
recombination
Yes – however, homologous sequences
are needed for recombination
Yes –
(Continued)
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Table 4 | Continued
Assembly
method
Mechanism Sequence independent* Scar-less
assembly
Software support tools
MAGE and
CAGE
In vivo homologous
recombina-
tion/conjugation
Yes – however, homologous sequences
are needed for recombination
Yes MAGE oligonucleotide design tools:
MODEST (Colloms et al., 2014)
http://modest.biosustain.dtu.dk/; optMAGE
http://arep.med.harvard.edu/optMAGE/
Yeast TAR In vivo homologous
recombination
Yes Yes –
Engineered
nucleases
(zinc-finger
nucleases,
TALENs, and
CRISPR/Cas9)
DNA cleavage and
non-homologous
end joining (NHEJ) or
homology-directed
repair (HDR)
Yes – cleavage can be directed toward
sequence of interest
Yes*,
However
NHEJ can
introduce
random
mutations.
E-CRISP: CRISPR target site identification
(Heigwer et al., 2014).
http://e-crisp-test.dkfz.de/E-CRISP/
SIRA Serine integrase
recombinational
assembly
Yes – as long as φC31 recombination
sites are avoided
No Software support tools are in development
(Colloms et al., 2014)
DNA synthesis Polymerase cycling
assembly from pools
of overlapping
custom oligos
Yes – however, repeat sequences or
high GC content can be problematic
Yes Codon optimization, the removal of
undesirable restriction sites and the
specification of 5′ and 3′ sequences are
possible during the order processes of
several commercial companies.
GeneDesigner (Villalobos et al., 2006) https:
//www.DNA20.com/resources/genedesigner
*Sequence-independent assembly strategies do not place restrictions upon which DNA sequences are permitted within assembly fragments.
integrated. As an example of such an approach, Isaacs et al. (2011)
used a MAGE–CAGE strategy to replace 314 TAG stop codons with
the synonymous TAA in E. coli across its entire genome (Isaacs
et al., 2011).
Engineered nucleases, which cleave specific DNA sequences,
creating double-stranded DNA breaks, can be used to intro-
duce genomic changes. These strategies depend upon the random
occurrence of perturbations in DNA repair mechanisms, where
double-stranded breaks are inappropriately repaired, resulting in
erroneous sequence insertions, deletions, or even significant chro-
mosomal rearrangements. Screening strategies to identify cells that
contain desirable genomic alterations can be subsequently isolated
as an engineered population. Zinc-finger nucleases (Ellis et al.,
2013), TALENS (Mahfouz et al., 2011), and the CRISPR/Cas sys-
tem (Sander and Joung, 2014) have all been engineered for these
types of genome editing applications. The CRISPR/Cas system
is particularly interesting since as discussed above, a deactivated
Cas9 nuclease:gRNA complex can also be fused with domains that
act as transcriptional activators or repressors (Bikard et al., 2013;
Mali et al., 2013; Qi et al., 2013). Nuclease-mediated genome
editing strategies can also be combined with a recombineering-
type approach, in which an engineered dsDNA can be introduced
into the cell, which has sequence complementarity at the site
of the nuclease breakage. Through the endogenous homologous
recombination machinery (DNA repair mechanisms), it is possible
to rationally integrate the engineered dsDNA into the genome
(Cong et al., 2013; Sander and Joung, 2014). Thus in combination,
MAGE, CAGE, and engineered, targeted nucleases (Zinc, TALENS
and Cas9) represent a set of molecular tools that enable genome
editing and the transcriptional control of natural and synthetic
genomes.
DNA SYNTHESIS
Synthetic biology has greatly benefited from the rapid decline
in the cost of commercial gene synthesis, a phenomenon pop-
ularized by the Carlson curve (Carlson, 2009), which is analo-
gous to Moore’s law. Although the rate of decline has decreased
in recent years, with DNA synthesis costs now relatively stable
(Carlson, 2009, http://www.synthesis.cc/cgi-bin/mt/mt-search.
cgi?blog_id=1&tag=CarlsonCurves&limit=20), it is likely that
new disruptive technologies will decrease DNA synthesis costs
in the near future. DNA synthesis costs are still sufficiently low
that many research groups routinely order the synthesis of genes
and gene fragments although still prohibitive for library gener-
ation or for the synthesis of large multi-part pathways. In these
cases, gene synthesis can be combined with additional cloning
techniques such as overlap-directed assembly or mutagenic PCR
to generate large constructs or biopart libraries, respectively. It is
likely that as DNA synthesis costs decline, there will be a continual
shift away from DNA assembly toward de novo DNA synthesis,
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which will have a transformative effect on synthetic biology and
the design-build-test cycle.
RAPID PROTOTYPING
High-throughput platforms bring scalability to biopart charac-
terization efforts, through the parallel characterization of func-
tion and context of entire biopart libraries (Arkin, 2013; Keren
et al., 2013; Mutalik et al., 2013b). To ensure consistency at
such scale, high-throughput workflows typically couple liquid-
handling robots with plate readers (Keren et al., 2013), flow
cytometry (Piyasena and Graves, 2014; Zuleta et al., 2014), or
microfluidics (Lin and Levchenko, 2012; Benedetto et al., 2014)
in order to automate the majority of the experimental work-
flow. Several high-throughput platforms have been described, the
majority of which were used to characterize DNA regulatory ele-
ments (Keren et al., 2013; Mutalik et al., 2013a,b), however, this
is expanding to include the characterization of enzymes (Choi
et al., 2013), multi-gene operons (Chizzolini et al., 2013), and RNA
aptamers (Cho et al., 2013; Szeto et al., 2014). When coupled with
automated data analysis and modeling, these technologies and
workflows could become rapid prototyping platforms, enabling
a truly biological design cycle approach (Kitney and Freemont,
2012). At present, these high-throughput workflows are typically
semi-rational design strategies in which thousands of biopart vari-
ants are tested and screened as part of a discovery workflow. Yet,
at the same time, these approaches are simultaneously generating
large data sets that provide useful insights into biological processes
that may inform biological design rules. For example, character-
ization efforts have informed several systematic methodologies
for the rational optimization of synthetic systems at the tran-
scriptional, translational, and post-translational level (Table 2)
(Arkin, 2008; Arpino et al., 2013; Reeve et al., 2014). In cases
where synthetic systems could conceivably be rationally designed,
it is still naïve to assume that the first iteration of a synthetic
biological system will perfectly match the design specifications.
Instead, multiple iterations of the design-build-test cycle will be
needed until forward-design approaches are sufficiently advanced.
Therefore, the requirements of interoperable standards in which
researchers can apply the same protocols across different liquid-
handling platforms are essential. To this end, Linshiz et al. (2013)
have implemented a high-level robot programing language (PaR-
PaR), which can translate biological protocols into instruction sets
for an extendable range of liquid-handling robot platforms. As a
consequence of this approach, the training requirements for end-
users to implement the same biological protocol across different
liquid-handlers are significantly reduced (Linshiz et al., 2013). If,
as the authors propose, PaR–PaR is combined with SBOL, then
the adoption of PaR–PaR scripts will enable researchers to share
the same high-throughput DNA assembly or characterization pro-
tocols, but have them implemented across different experimental
and equipment setups.
The majority of the rapid prototyping platforms that we have
described so far have been optimized for testing biological parts,
devices, and systems in vivo; however, in vitro systems are emerg-
ing as a useful testing platform. Cell-free protein synthesis (CFPS)
systems based upon E. coli (Nirenberg and Matthaei, 1961; Sitara-
man et al., 2004; Hong et al., 2014), B. subtilis (Zaghloul and
Doi, 1987), S. cerevisiae (Hodgman and Jewett, 2013; Gan and
Jewett, 2014), or other cell extracts have been reported in the
scientific literature for several decades. Several CFPS systems are
commercially available and are principally marketed as protein
expression systems. Optimized E. coli CFPS systems can synthe-
size up to 2.3 mg/ml of the target protein (Caschera and Noireaux,
2014), including those that are toxic in vivo. In recent years, the
synthetic biology community has repurposed CFPS systems as
in vitro transcription–translation (TX–TL) coupled characteriza-
tion platforms. A typical TX–TL reaction combines a synthetic
system encoded into plasmid, linear or closed circular DNA, with
cell-free extract, and a reaction buffer, the contents of which can
be optimized (Sun et al., 2013a). For instance, the addition of mal-
todextrin (Wang and Zhang, 2009) and to a lesser degree maltose
(Caschera and Noireaux, 2014) as an additional energy source can
increase protein production, essentially prolonging the duration
of in vitro reactions for up to 10 h.
Transcription–translation characterization systems provide
characterization data within a timescale of hours (Chappell et al.,
2013), and are therefore, amenable to a rapid prototyping work-
flow (Chappell et al., 2013; Sun et al., 2013b). For instance, Chap-
pell et al. (2013) characterized a panel of Anderson constitutive
promoters, using a commercially available TX–TL system, within
a 5-h workflow. Interestingly, the in vitro characterization data of
a set of Anderson promoters correlated with their performance
in vivo (Chappell et al., 2013). Likewise, in the same study, a panel
of LasR responsive, AHL-inducible promoters, also behaved simi-
larly in vitro and in vivo, although meaningful comparisons could
only be made where constructs were encoded into plasmid or
closed circular DNA (Chappell et al., 2013). PCR-generated lin-
ear DNA templates did not produce sufficient transcription and
translation of the reporter protein (Chappell et al., 2013). Based
upon several reports, it is likely that linear DNA templates are
unstable in vitro due to the presence of exonuclease activity in the
cell-free extract (Sitaraman et al., 2004; Sun et al., 2013b). Expres-
sion of the phage lambda protein Gam, an inhibitor of RecBCD
(ExoV), along with other modifications, can minimize linear DNA
degradation, thus restoring protein expression to levels that are
comparable to plasmid DNA constructs (Sitaraman et al., 2004;
Sun et al., 2013b). Yet, in disagreement with several other studies
(Chappell et al., 2013; Iyer et al., 2013; Lu and Ellington, 2014), Sun
et al. (2013b) reported that in vitro characterization data were not
comparable to in vivo data, though they did describe a methodol-
ogy to calibrate between them. While the comparability between
in vitro and in vivo characterization requires further investigation,
several reports have demonstrated that cell-free TX–TL systems
have proven utility in the rapid prototyping of logic-based genetic
circuits (Karig et al., 2012; Shin and Noireaux, 2012; Iyer et al.,
2013) or synthetic operons (Lu and Ellington, 2014). Within a sys-
tematic design context, in vitro characterization approaches have
the potential to complement in vivo prototyping efforts by rapidly
providing the characterization data required to rationally select a
smaller number of designs for final testing (Figure 3).
CONCLUSION
Synthetic biology is generally described as the“engineering of biol-
ogy” yet since its inception, the field has faced the well-understood
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FIGURE 3 | Systematic design of biological systems. The biological
design cycle is one of several engineering principles that have been
adopted in synthetic biology, and it describes the iterative process of
designing a biological system through multiple rounds of design, build, and
testing. To ensure that iterations of the design cycle are informative, the
systematic capture, and integration of experimental and experiential data
within a biological design workflow, such as the one shown here, is
desirable.
reality that biological systems are complex, stochastic, and diffi-
cult to predict, and are therefore, intrinsically difficult to engineer.
In order to address these fundamental challenges, synthetic biol-
ogy must use and explore the existing large body of knowledge
of biological systems at different scales from molecular to cellular
to organismal. By establishing a systematic design framework in
which existing biological knowledge can be adapted and utilized
will ensure the rapid development of successful applications using
synthetic biology. Furthermore, the accumulated measurements
and acquired knowledge of many synthetic biology experiments
will allow synthetic biologists to establish design rules that tackle
biological complexity, such that robust biological systems can be
designed, assembled, and prototyped as part of a biological design
cycle. At each stage of the design cycle, an expanding repertoire
of tools is being developed. In this review, we have highlighted
several of these tools in terms of their applications and benefits to
the synthetic biology community within the context of the syn-
thetic biology design cycle namely, designing predictable biology
(design), assembling DNA into bioparts, pathways, and genomes
(build), and rapid prototyping (test).
Design encompasses the development of tools and methodolo-
gies that make it easier to forward-design predictable synthetic
biological systems. While there are several areas that are critical to
designing predictable biology including, chassis selection, biopart
design, or engineering strategies, as well as, several accompanying
in silico design tools, we would argue that measurement and char-
acterization (metrology) of biological parts, devices, and systems
is essential for the field of synthetic biology to fulfill its promise.
It is only through improvements in our ability to measure and
generate meaningful conclusions about the behavior of biological
processes that the field can progress in terms of unlocking addi-
tional biological design rules. The RBS calculator is the current
exemplar of this perspective, though further work is required to
equip the synthetic biology toolbox with the tools to make it easier
to engineer radically complex synthetic biological parts, devices,
and systems.
Build encompasses DNA assembly and genome-engineering
methods that enable synthetic systems to be assembled. The field
has benefited immensely from the BioBrick assembly standard.
BioBrick assembly, effectively making bioparts reusable (modular)
at the physical DNA level, creates a standard that enables multiple
research groups to use and share an expanding library of bioparts,
without the need for bespoke cloning strategies. While limita-
tions in the BioBrick assembly standard led to the emergence of
powerful overlap-directed assembly methods, including Gibson,
these methods also shifted away from several of the core prin-
cipals of synthetic biology since these methods rely on bespoke
cloning strategies. However, emerging DNA assembly methods
including MODAL or Gibson with UNSes, aim to unify the advan-
tages of overlap-directed assembly with the engineering principle
of modularity. However, advances in DNA synthesis and resultant
reduction of costs could radically transform the field, such that
more time could be diverted away from DNA assembly toward the
designing or testing of synthetic systems.
Test encompasses elements of biopart characterization, since
even the testing of non-functional designs may provide insights
into our understanding of the biological design rules. Liquid-
handling robot high-throughput characterization platforms,along
with plate readers are equipped to test prototypes of synthetic
bioparts, devices, and systems. However, these systems benefit
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from the addition of flow cytometry and microfluidics, which
bring single cell analysis to these platforms. Thus, individual cells
could be analyzed and selected based upon preferred biological
performance from a heterogeneous cell mix. Additionally, an array
of emerging in vitro TX–TL cell-free characterization systems pro-
vide characterization data within a timescale of hours, and are
therefore, amenable to a rapid prototyping workflow. Such sys-
tems are complementary to in vivo high-throughput approaches
and may speed up iterations through the design cycle by reducing
the number of final designs that need to be tested.
As the synthetic biology toolkit expands and more design rules
are unlocked, the most successful forward-design strategies are
likely to be those that encompass a diverse workflow that combines
several interoperable tools at each stage of the design cycle.
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